Biomarker Lead

**ABOUT ITEOS THERAPEUTICS, INC**

iTeos Therapeutics is a publicly-traded (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of patients with cancer by designing and developing next generation immunotherapies.

Based in Gosselies, Belgium and Watertown, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the Duve Institute (UCLouvain) in 2011.

In March 2020, the Company completed a $125 million Series B2 financing, and in July 2020, we completed our IPO, raising over $230 million of gross proceeds. In June 2021, the Company entered into a transformative $2.145 billion co-development and co-commercialization agreement with GSK for EOS-448, the Company’s anti-TIGIT monoclonal antibody. As a well-capitalized biotech company, we are positioned to continue to develop our clinical pipeline and maintain our investments in our discovery research team to leverage our innovative science to improve the lives of patients with cancer.

**iTeos Therapeutics is now a world-class actor in the sector. To carry on its growth and reinforce its **Translational Medicine (TM) department**, iTeos Therapeutics is looking for a **Biomarker Leader**.**

**ROLE**:Biomarker Leader**

**MAIN RESPONSIBILITIES**
- Actively participating in the development of Biomarker and Precision Medicine enabling strategies for cutting-edge Cancer Immunotherapy projects.
- For on-going clinical studies, perform complex data analysis from pharmacodynamic and patient selection biomarker testing across several functional areas and interpret them.
- Participatein the selection, development and implementation of assays to measure pharmacodynamic, predictive, prognostic, and safety biomarkers.
- Contribute to the growth and further development of the TM team.

**PROFESSIONAL EXPERIENCE/QUALIFICATIONS**
- PhD, MD/PhD in Cancer Immunotherapy, Immunology, or Molecular Biology with a minimum of 3 years of relevant post-doctoral research experience in analyzing human samples and/or monitoring analysis of biological markers during clinical trials.
- Must have expertise in Immuno-Oncology or Immunology.
- Previous experience in Biotech/Pharma industry and oncology drug development is clearly a plus.
- Direct experience with the discovery and characterization of biomarkers using flow cytometry, proteomics, molecular biology and/or immunohistochemistry of human tissue specimens.Experience with single cells technologies (ie scRNAseq) and/or multi-omics approaches (ie spatial omics) is a plus.
- Experience in implementing bioassays in clinical studies and analyzing corresponding data.
- Understanding of GCP/GCLP guidelines and current global regulations.
- Mastering Office tools as well as data analysis software (eg xls, Prism, Jump).
- Fluent in English (oral and written). French is a plus.
- Strong project, organization, and interpersonal skills.
- Resilience with the ability to adapt to changes in priorities and to work effectively on multiple programs in a fast-paced environment.
- Although largely expected to work independently, you must be a team-player, capable to collaborate effectively with internal and external stakeholders.

**OFFER**
- A stimulating position within a high-potential innovative biotech company.
- The opportunity to work in a science-driven, dynamic, respectful, and professional environment.
- A challenging scientific and business growth in which you get to bring your knowledge and skills.
- An employment agreement contract with an attractive salary package in line with the position responsibilities and your experience.

**RECRUITMENT PROCESS